Novel model for accurately predicting curative effect of breast cancer immunotherapy and application thereof
The invention discloses a novel model for accurate prediction of curative effect of breast cancer immunotherapy and application thereof, the model contains IFN-gamma, aSMA, collagen-I and Vimentin, according to the model, prognosis and treatment effect of immunotherapy of a breast cancer patient can be accurately predicted, high score prompts that the breast cancer patient can be benefited by adopting an immunotherapy strategy, and the model can be used for accurately predicting the curative effect of immunotherapy of the breast cancer patient. The model provided by the invention has guiding significance for predicting the long-term curative effect of breast cancer immunotherapy patients, and has wide clinical applicability..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 29. Juli Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MA FEI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-07-29, Last update posted on www.tib.eu: 2022-11-22, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN114807370 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA015902978 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA015902978 | ||
| 003 | DE-627 | ||
| 005 | 20230503184339.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA015902978 | ||
| 035 | |a (EPA)CN114807370 | ||
| 035 | |a (EPA)82511458 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MA FEI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel model for accurately predicting curative effect of breast cancer immunotherapy and application thereof |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-07-29, Last update posted on www.tib.eu: 2022-11-22, Last updated: 2023-02-09 | ||
| 520 | |a The invention discloses a novel model for accurate prediction of curative effect of breast cancer immunotherapy and application thereof, the model contains IFN-gamma, aSMA, collagen-I and Vimentin, according to the model, prognosis and treatment effect of immunotherapy of a breast cancer patient can be accurately predicted, high score prompts that the breast cancer patient can be benefited by adopting an immunotherapy strategy, and the model can be used for accurately predicting the curative effect of immunotherapy of the breast cancer patient. The model provided by the invention has guiding significance for predicting the long-term curative effect of breast cancer immunotherapy patients, and has wide clinical applicability. | ||
| 650 | 4 | |a G16B: Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology | |
| 650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
| 650 | 4 | |a G16H: Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a QIAN HAILI |4 aut | |
| 700 | 0 | |a MO HONGNAN |4 aut | |
| 700 | 0 | |a QIAN TIANYI |4 aut | |
| 700 | 0 | |a HAN JIASHU |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 29. Juli |
| 773 | 1 | 8 | |g year:2022 |g day:29 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/82511458/publication/CN114807370A1?q=CN114807370 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2022 |b 29 |c 07 |
| 951 | |a AR | ||
| 952 | |j 2022 |b 29 |c 07 | ||